Jacobs Levy Equity Management’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.26M | Sell |
119,338
-16,941
| -12% | -$179K | 0.01% | 714 |
|
|
2025
Q1 | $2.05M | Buy |
136,279
+17,303
| +15% | +$260K | 0.01% | 654 |
|
|
2024
Q4 | $1.96M | Buy |
+118,976
| New | +$1.96M | 0.01% | 592 |
|
|
2022
Q3 | – | Sell |
-16,397
| Closed | -$366K | – | 991 |
|
|
2022
Q2 | $366K | Buy |
+16,397
| New | +$366K | ﹤0.01% | 903 |
|
|
2019
Q3 | – | Sell |
-9,768
| Closed | -$397K | – | 917 |
|
|
2019
Q2 | $397K | Sell |
9,768
-8,980
| -48% | -$365K | 0.01% | 775 |
|
|
2019
Q1 | $567K | Buy |
+18,748
| New | +$567K | 0.01% | 763 |
|
|
2014
Q1 | – | Sell |
-12,040
| Closed | -$459K | – | 888 |
|
|
2013
Q4 | $459K | Sell |
12,040
-1,200
| -9% | -$45.7K | 0.01% | 726 |
|
|
2013
Q3 | $316K | Buy |
13,240
+500
| +4% | +$11.9K | 0.01% | 784 |
|
|
2013
Q2 | $217K | Buy |
+12,740
| New | +$217K | ﹤0.01% | 879 |
|